Product category:
Laboratory and scientific books and publishing
News Release from: Frost and Sullivan | Subject: World Drug Discovery Spending A442
Edited by the Laboratorytalk Editorial
Team on 24 February 2004
Strategic analysis of drug discovery
spending
Drug discovery companies focus on strong product line to offset R and D budget slowdown, according to this analysts' report
One of the most persistent challenges facing manufacturers and distributors of research products is the slowed growth of R and D spending for all segments of the drug discovery market While pharmaceutical companies are affected by slow top line growth, biotechs need to become more product-oriented, reducing R and D spending
This article was originally published on Laboratorytalk on 2 Aug 2002 at 8.00am (UK)
Related stories
Smart materials: the new frontier of technology
Analysis reveals the advances made in the development of industrial applications for smart, active, or engineered materials, including their use in smart structures
Ready for convergence?
The convergence of nanotechnology, biotechnology, information technology, and cognitive science will have a substantial impact on companies and markets in the future
However, increased pressure on pharmaceutical companies to speed up discovery and development of new therapies, coupled with the critical need to expand market growth, is likely to drive R and D spending.
"With many of the top drug discovery biotechnology companies evolving into product-focussed pharmaceuticals businesses and capitalising on strong product pipelines, revenues are likely to continue to experience growth," says Isaac Meek, industry analyst for Frost and Sullivan's drug discovery technology group.
"Top agribiotech companies are also expected to benefit from a continued demand for agricultural biotech crops".
Further reading
European cardiac risk assessment markers
Elevated European CHF mortality rates and introduction of premium-priced assays stimulate uptake of cardiac risk assessment markers, according to new research
Bubble bursts in defoamer market
Negative growth will force European pulp and paper defoamer suppliers to recognise commodity market, says new report
Following a difficult 2002 - the result of the economic downturn, reductions in biotech/pharma R and D spending, and consolidations - a slight increase in R and D spending was experienced in 2003.
There are now positive signs of recovering pharma budgets and enhanced outlays on bio warfare.
Overall, the outlook is one of 'cautious optimism' for this year.
Global drug discovery spending, which was $19.6 billion in 2002, is expected to reach $25.1 billion in 2006.
The shift to data mining and computational techniques has been one of the factors affecting the drug discovery industry.
This has influenced the sales of consumables, reagents and instruments.
While there has been continued growth of separation products for nucleic acids and proteins, there has been a simultaneous decrease in purchase of capital equipment and related sequencing consumables.
Research product manufacturers need to strategise by developing innovative technologies in genomics and proteomics and offering sophisticated research equipment with higher throughput and greater sensitivity.
Such product innovation is also likely to offset the slowed growth of National Institutes of Health (NIH) budget.
Cutbacks in NIH funding - one of the single greatest contributors to research product sales - is forcing academic and government research groups to manage R and D costs and decrease the average cost per experiment, overall limiting the growth of research product manufacturers.
Today, customer priority in the drug discovery sector has progressed from the basic cost and availability to include ease-of-use, novelty, efficacy and miniaturisation and standardisation of equipment.
By catering to consumer demands, research product manufacturers can anticipate benefits and look to improving market share.
• Frost and Sullivan: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
